课题基金 / 基金详情

项目摘要

项目成果

Mark A. Hlatky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heart disease is the leading cause of death in the United States, and half of those deaths are sudden and unexpected, occurring within an hour of onset of symptoms. Cardiac arrhythmias can lead to sudden death, and have been strong risk factors in epidemiologic studies. The value of screening for and treating disturbances of cardiac rhythm is uncertain, however, since recent trials of antiarrhythmic drugs have shown potential harm. Many physicians are now turning to implantible cardiac defibrillators (ICD's), which are now easy to implant and effective at converting arrhythmia despite the cost of over $30,000 each, ICD's are poised for explosive growth in use to treat patients at risk of sudden death. The purpose of the Cardiac Arrhythmia PORT is to develop a comprehensive decision model for the screening and treatment of patients at risk for sudden cardiac death that incorporate information about a range of outcomes (mortality, morbidity, functional status, quality of life, and cost) as well as patient preferences. To accomplish this overall goal, we will perform six inter-related projects: l) use administrative data to document costs of arrhythmia management, and factors that affect variations in practice patterns and cost; 2) perform a nested case-control study to determine specific risk factors for, sudden cardiac death; 3) synthesize the literature about the efficacy of antiarrhythmic management and other forms of cardiac therapy on sudden death; 4) document in a prospective patient cohort the effectiveness of alternative management strategies on a broad array of outcomes, including functional status, quality of life, and cost; 5) determine patient values and preferences relevant to management decisions, and examine how these factors affect the effectiveness of antiarrhythmic management; and 6) construct a decision model that incorporates data on medical effectiveness and preferences and that will support clinical management recommendations to translate these research finding into clinical practice.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Publishing web-based guidelines using interactive decision models.
使用交互式决策模型发布基于网络的指南。
DOI: 10.1046/j.1365-2753.2001.00271.x
发表时间: 2001
期刊: Journal of evaluation in clinical practice
影响因子: 2.4
作者: [Sanders,GD, NeaseJr,RF, Owens,DK]
通讯作者: Owens,DK
Cost-effectiveness of the implantable cardioverter defibrillator.
植入式心脏复律除颤器的成本效益。
DOI: 10.1023/b:cepr.0000023153.81976.3a
发表时间: 2003
期刊: Cardiac electrophysiology review
影响因子: --
作者: [Hlatky,MarkA, Sanders,GillianD, Owens,DouglasK]
通讯作者: Owens,DouglasK
Distributed decision support using a web-based interface: prevention of sudden cardiac death.
使用基于网络的界面进行分布式决策支持:预防心源性猝死。
DOI: 10.1177/0272989x9901900206
发表时间: 1999
期刊: Medical decision making : an international journal of the Society for Medical Decision Making
影响因子: --
作者: [Sanders,GD, Hagerty,CG, Sonnenberg,FA, Hlatky,MA, Owens,DK]
通讯作者: Owens,DK
DOI: 10.1016/s0002-9149(98)00417-2
发表时间: 1998
期刊: The American journal of cardiology
影响因子: --
作者: [Every,NR, Hlatky,MA, McDonald,KM, Weaver,WD, Hallstrom,AP]
通讯作者: Hallstrom,AP
25
    Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk
    • 批准号:
      10015327
    • 项目类别:
    • 资助金额:
      $219.21万
    • 财政年份:
      2018
    • 负责人:
      Mark A. Hlatky
    • 依托单位:
    Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk
    • 批准号:
      10246433
    • 项目类别:
    • 资助金额:
      $227.83万
    • 财政年份:
      2018
    • 负责人:
      Mark A. Hlatky
    • 依托单位:
    Improved Estimates of the Comparative Treatment Effects of CABG and PCI
    • 批准号:
      7937737
    • 项目类别:
    • 资助金额:
      $49.91万
    • 财政年份:
      2009
    • 负责人:
      Mark A. Hlatky
    • 依托单位:
    Improved Estimates of the Comparative Treatment Effects of CABG and PCI
    • 批准号:
      7822491
    • 项目类别:
    • 资助金额:
      $49.98万
    • 财政年份:
      2009
    • 负责人:
      Mark A. Hlatky
    • 依托单位:
    海外基金